ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
|Principal Investigator's Name:||Vivian Lanius|
|Institution:||Bayer Schering Pharma AG|
|Department:||Global Biostatistics, Clinical Statistics|
|Proposed Analysis:||To derive useful information for the planning of a clinical trial in non-demented subjects with MCI in order to test the predictive value of a PET tracer to predict progression to AD-type dementia|
|Investigator's Name:||Michael Kunz|
|Proposed Analysis:||To improve the planning of a clinical trial in non-demented persons with MCI to evaluate the predictive value of a PET tracer to predict progression to AD-type dementia|